Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries

被引：0
作者：
Manuel Hens
Ana Villaverde-Hueso
Veronica Alonso
Ignacio Abaitua
Manuel Posada de la Paz
机构：
[1] Instituto de Salud Carlos III,Rare Diseases Research Institute
[2] Centro de Investigacion Biomedica en Red de Enfermedades Raras (CIBERER),undefined
来源：
The European Journal of Health Economics | 2014年 / 15卷
关键词：
Migraine; Therapy; Triptans; Cost-effectiveness; Health economics; Treatment; I10; I13; I18;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：433 / 437
页数：4
相关论文
共 105 条
  • [81] Evers S(undefined)undefined undefined undefined undefined-undefined
  • [82] Afra J(undefined)undefined undefined undefined undefined-undefined
  • [83] Frese A(undefined)undefined undefined undefined undefined-undefined
  • [84] Goadsby PJ(undefined)undefined undefined undefined undefined-undefined
  • [85] Linde M(undefined)undefined undefined undefined undefined-undefined
  • [86] May A(undefined)undefined undefined undefined undefined-undefined
  • [87] Sandor PS(undefined)undefined undefined undefined undefined-undefined
  • [88] Sculpher M(undefined)undefined undefined undefined undefined-undefined
  • [89] Barbieri M(undefined)undefined undefined undefined undefined-undefined
  • [90] Drummond M(undefined)undefined undefined undefined undefined-undefined
234567891011